化、放疗合用对局限性小细胞肺癌(LSCLC)患者的长期生存有重要的意义,但化疗和胸部放疗的应用顺序和应用时间仍有争议。作者报道了1988年2月至1992年8月的28例LSCLC接受交替化、放疗(IDG);33例化、放疗同时进行(CON)的一组病例。所有病例均经组织细胞学证实,病变局限于一侧胸腔。IDG组Ⅱ期4例,Ⅱ~A例,Ⅲ~B11例。CON组 Chemotherapy and radiotherapy combined have important implications for the long-term survival of patients with localized small cell lung cancer (LSCLC), but the application sequence and application time of chemotherapy and thoracic radiotherapy are still controversial. The authors reported a series of 28 cases of LSCLC receiving alternating and radiotherapy (IDG) from February 1988 to August 1992; 33 cases of concurrent chemotherapy and radiotherapy (CON). All cases were confirmed by histology and cytology. Lesions were confined to one side of the chest. In the IDG group, 4 cases were in stage II, II~A cases, and III~B11 cases. CON group